Peng Z - Search Results

1

Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation.

Peng Z, Lv SJ, Chen H, Rao H, Guo Z, Wan Q, Yang J, Zhang Y, Liu DP, Chen HZ, Wang M. Peng Z, et al. Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):e1-e14. doi: 10.1161/ATVBAHA.123.320391. Epub 2024 Nov 26. Arterioscler Thromb Vasc Biol. 2025. PMID: 39588646

2

Endothelial Response to Pathophysiological Stress.

Peng Z, Shu B, Zhang Y, Wang M. Peng Z, et al. Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):e233-e243. doi: 10.1161/ATVBAHA.119.312580. Epub 2019 Oct 23. Arterioscler Thromb Vasc Biol. 2019. PMID: 31644356 Review.

3

Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics.

Zhang Y, Li H, Huang Y, Chen H, Rao H, Yang G, Wan Q, Peng Z, Bertin J, Geddes B, Reilly M, Tran JL, Wang M. Zhang Y, et al. Among authors: peng z. Front Cardiovasc Med. 2021 Oct 25;8:715337. doi: 10.3389/fcvm.2021.715337. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34760938 Free PMC article.

4

Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.

Wan Q, Xu C, Zhu L, Zhang Y, Peng Z, Chen H, Rao H, Zhang E, Wang H, Chu F, Ning X, Yang X, Yuan J, Wu Y, Huang Y, Hu S, Liu DP, Wang M. Wan Q, et al. Among authors: peng z. Circ Res. 2022 Aug 19;131(5):442-455. doi: 10.1161/CIRCRESAHA.122.321365. Epub 2022 Jul 28. Circ Res. 2022. PMID: 35899614

5

Identification of the biological processes, immune cell landscape, and hub genes shared by acute anaphylaxis and ST-segment elevation myocardial infarction.

Peng Z, Chen H, Wang M. Peng Z, et al. Front Pharmacol. 2023 Jul 4;14:1211332. doi: 10.3389/fphar.2023.1211332. eCollection 2023. Front Pharmacol. 2023. PMID: 37469874 Free PMC article.

6

Complement factor B, not the membrane attack complex component C9, promotes neointima formation after arterial wire injury.

Guo Z, Zhang Y, Peng Z, Rao H, Yang J, Chen Z, Song W, Wan Q, Chen H, Wang M. Guo Z, et al. Among authors: peng z. Atherosclerosis. 2024 Dec;399:118586. doi: 10.1016/j.atherosclerosis.2024.118586. Epub 2024 Oct 23. Atherosclerosis. 2024. PMID: 39500113

7

Drug Discovery for Coronary Artery Disease.

Wan Q, Qian S, Huang Y, Zhang Y, Peng Z, Li Q, Shu B, Zhu L, Wang M. Wan Q, et al. Among authors: peng z. Adv Exp Med Biol. 2020;1177:297-339. doi: 10.1007/978-981-15-2517-9_8. Adv Exp Med Biol. 2020. PMID: 32246449 Review.

8

The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice.

Hao H, Ma X, Chen H, Zhu L, Xu Z, Li Q, Xu C, Zhang Y, Peng Z, Wang M. Hao H, et al. Among authors: peng z. J Cell Mol Med. 2020 Sep;24(17):9638-9645. doi: 10.1111/jcmm.15476. Epub 2020 Aug 18. J Cell Mol Med. 2020. PMID: 32810369 Free PMC article.

9

[The holistic-medicinal approach of diagnosis and treatment of sexual transmitted diseases by integrated traditional and Western medicine].

Wang MH, Peng ZH, Wang FL. Wang MH, et al. Among authors: peng zh. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996 Nov;16(11):690-2. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996. PMID: 9772622 Chinese. No abstract available.

10

Long-term Survival Case of SCLC Transformation After Osimertinib Resistance in EGFR-mutant NSCLC: Benefits from Chemo-immunotherapy Combined with Anti-angiogenic Therapy Followed by Osimertinib Rechallenge.

Liu D, Ding K, Li X, Peng Z, Xu Y. Liu D, et al. Among authors: peng z. Cancer Lett. 2025 Jan 23:217474. doi: 10.1016/j.canlet.2025.217474. Online ahead of print. Cancer Lett. 2025. PMID: 39862917 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,239 results

Search Page

Filters